Polónia Jorge, Barbosa Loide, Silva José A, Maldonado João
Unidade Hipertensão e Risco Cardiovascular, Hospital Pedro Hispano, Matosinhos, Portugal.
Rev Port Cardiol. 2003 Dec;22(12):1485-92.
To evaluate in hypertensive patients (pts) with similar peripheral blood pressure (BP) whether different antihypertensive treatments have different influences on aortic stiffness, aortic central pressures and aortic wave reflections.
In a cross-over study 41 nondiabetic hypertensives (21 women, age 35-60 yrs) were evaluated after stabilized (> 4 months) antihypertensive treatment and with casual BP between 130/80 and 160/95 mmHg. Patients were divided into 3 groups: Group I--12 pts all medicated with beta-blockers; Group II--14 pts all medicated with calcium channel blockers; Group III--15 pts all medicated with either angiotensin-converting enzyme inhibitors (ACEIs) (n = 8) or angiotensin II receptor blockers (ARBs) (n = 7). We evaluated casual BP and carotid-femoral pulse wave velocity (PWV). Systolic blood pressure (SBP) and pulse pressure (PP), left ventricular ejection duration (LVED), augmentation pressure (delta P) and augmentation index (AI%) in the aorta (a measure of aortic wave reflection), derived using radial and carotid applantation tonometry, were measured. Data are means + SEM.
For similar casual peripheral BP values, group III vs. group I showed lower (p < 0.05) values of: aortic stiffness--PWV (10.3 +/- 0.2 vs. 11.2 +/- 0.3 m/s), central PP (48 +/- 2 vs. 55 +/- 2 mmHg), delta TP (11 +/- 3 vs. 21 +/- 3 mmHg), LVED (297 +/- 5 vs. 319 +/- 8 ms), AI% (22 +/- 4 vs. 39 +/- 3%), suggesting reduced vascular tone in the arteries and greater brachial-aortic PP amplification. Data in group II did not differ significantly from the other two groups.
Independently of casual BP values, the three classes of antihypertensive drugs appear to have different influences on aortic stiffness, central pressures and aortic wave reflections, ACEIs or ARBs appearing to exhibit a more favorable profile.
评估外周血压(BP)相似的高血压患者中,不同的降压治疗对主动脉僵硬度、主动脉中心血压和主动脉波反射是否有不同影响。
在一项交叉研究中,对41例非糖尿病高血压患者(21例女性,年龄35 - 60岁)进行评估,这些患者经过稳定(>4个月)的降压治疗,随机血压在130/80至160/95 mmHg之间。患者分为3组:第一组——12例患者均使用β受体阻滞剂治疗;第二组——14例患者均使用钙通道阻滞剂治疗;第三组——15例患者均使用血管紧张素转换酶抑制剂(ACEIs)(n = 8)或血管紧张素II受体阻滞剂(ARBs)(n = 7)治疗。我们评估了随机血压和颈股脉搏波速度(PWV)。使用桡动脉和颈动脉压平式测压法测量主动脉的收缩压(SBP)和脉压(PP)、左心室射血持续时间(LVED)、增压(ΔP)和增压指数(AI%)(主动脉波反射的一种测量指标)。数据为均值±标准误。
对于相似的随机外周血压值,第三组与第一组相比,以下指标值较低(P < 0.05):主动脉僵硬度——PWV(10.3±0.2对11.2±0.3 m/s)、中心PP(48±2对55±2 mmHg)、ΔTP(11±3对21±�mmHg)、LVED(297±5对319±8 ms)、AI%(22±4对39±3%),提示动脉血管张力降低以及肱动脉-主动脉PP放大作用增强。第二组的数据与其他两组无显著差异。
独立于随机血压值,这三类降压药物似乎对主动脉僵硬度、中心血压和主动脉波反射有不同影响,ACEIs或ARBs似乎表现出更有利的特征。